Publisher Correction: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age.
Leukemia
View this publicationLeukemia
View this publicationJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
View this publicationFrontiers in oncology
View this publicationBMC rheumatology
View this publicationClinical rheumatology
View this publicationCancers
View this publicationPatterns (New York, N.Y.)
View this publicationJournal of cancer research and clinical oncology
View this publicationOncology research and treatment
View this publicationInternational journal of environmental research and public health
View this publication